New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 11, 2014
05:54 EDTCOH, TKMRStocks with implied volatility movement; COH TKMR
Stocks with implied volatility movement; Coach (COH) 37, Tekmira (TKMR) 138 according to iVolatility.
News For COH;TKMR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 3, 2015
19:33 EDTTKMRTekmira shareholders vote for OnCore Biopharma
Subscribe for More Information
15:57 EDTCOHBofA/Merrill retail analysts hold an analyst/industry conference call
Subscribe for More Information
March 2, 2015
09:47 EDTCOHCoach downgraded to Hold from Buy at Standpoint Research
Subscribe for More Information
06:28 EDTTKMRFujifilm CEO says 'ready' for large orders of Avigan drug for Ebola, WSJ reports
Fujifilm’s (FUJIY) Avigan drug, which has shown signs of efficacy against the Ebola virus, has drawn interest from about 20 countries, The Wall Street Journal reports, citing comments made by CEO Shigetaka Komori. The drug was developed by Toyama Chemical, a Fujifilm unit, and Komori said the company is ready for large orders. Other drug companies that are working on experimental Ebola vaccines or treatments include Peregrine (PPHM), Tekmira (TKMR), Sarepta (SRPT), BioCryst (BCRX), Chimerix (CMRX) and NewLink Genetics (NLNK). Reference Link
February 27, 2015
13:24 EDTTKMRLiberia, U.S. begin ZMapp ebola trial
In partnership with the Liberian government, the National Institute of Allergy and Infectious Diseases launched a clinical trial to obtain safety and efficacy data on the investigational drug ZMapp as a treatment for Ebola virus disease. The study may be expanded to test ZMapp against other treatments which may also include the following: Tekmira siRNA from Tekmira Pharmaceuticals (TKMR), Favipiravir from Toyama Chemical, BCX4430 from BioCryst (BCRX), and AVI-7537 from Sarepta (SRPT). The trial is expected to conclude in December 2016.
February 26, 2015
11:32 EDTTKMRTekmira to host special shareholder meeting
Subscribe for More Information
05:27 EDTTKMRTekmira announces update to proxy circular on merger with OnCore
Tekmira Pharmaceuticals announced an update to persons who will serve as members of the board of the company upon completion of the company's proposed business combination with OnCore Biopharma, as described in the company's proxy circular regarding the transaction, dated February 4. The board of the combined company upon completion of the merger will consist of Vivek Ramaswamy, who will serve as chairman of the board, Mark Murray, Ph.D., Richard Henriques, Jr., Keith Manchester, Frank Karbe, William T. Symonds, Pharm. D., and Herbert Conrad. Daniel Kisner, M.D., will not serve as a director or vice chairman of the board for the combined company.
February 25, 2015
07:31 EDTCOHCoach longer term outlook positive, says Stifel
Subscribe for More Information
February 24, 2015
10:00 EDTCOHOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
06:28 EDTCOHCoach upgraded to Outperform from Perform at Oppenheimer
Subscribe for More Information
February 20, 2015
07:14 EDTCOHOppenheimer to hold a tour
Subscribe for More Information
February 19, 2015
09:59 EDTCOHOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Altisource Residential (RESI) upgraded to Neutral from Sell at Compass Point... Angie's List (ANGI) upgraded to Overweight from Equal-Weight at First Analysis... Barrick Gold (ABX) upgraded to Buy from Hold at TD Securities... British Land (BTLCY) upgraded to Buy from Hold at Societe Generale... Coach (COH) upgraded to Buy from Hold at Topeka... Fiat Chrysler (FCAU) upgraded to Outperform from Neutral at Exane BNP Paribas... Garmin (GRMN) upgraded at BofA/Merrill... Hologic (HOLX) upgraded to Buy from Hold at Canaccord... Iberdrola (IBDRY) upgraded to Neutral from Underweight at HSBC... KPN (KKPNY) upgraded to Neutral from Underperform at Exane BNP Paribas... Monster Worldwide (MWW) upgraded at Evercore ISI... Pharmacyclics (PCYC) upgraded to Buy from Neutral at Nomura... RPC, Inc. (RES) upgraded to Equal Weight from Underweight at Morgan Stanley... Sanofi (SNY) upgraded to Buy from Neutral at BofA/Merrill... Sasol (SSL) upgraded to Neutral from Underweight at HSBC... Tractor Supply (TSCO) upgraded at Oppenheimer... Valero (VLO) upgraded to Buy from Hold at Deutsche Bank... Weingarten Realty (WRI) upgraded to Neutral from Sell at UBS... Werner (WERN) upgraded on improving freight fundamentals at RBC Capital... diaDexus (DDXS) upgraded to Buy from Neutral at Ladenburg,
06:30 EDTCOHCoach upgraded to Buy from Hold at Topeka
Topeka upgraded Coach to Buy and raised its price target to $44 from $40 following yesterday's Fall 2015 fashion week. The analyst is impressed how quickly Coach has changed its assortments under new design director Stuart Vevers. Topeka said there are more opening price points in handbags and improved cohesion between collection and core, creating a brand halo effect. Additionally, the firm's recent mall checks indicate a pickup in Coach store traffic.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use